YI

Yusuf Izhar Zaidi

Active Director Designated Partner DIN 11734894
DIN 11734894 First appointment May 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Yusuf Izhar Zaidi

Data last updated:

Yusuf Izhar Zaidi is a Designated Partner at Imperial Medical Centre Llp (since 2026).

DIN 11734894
Primary Designation Designated Partner
First Appointment 22 May 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner22 May 20262026Active

Board colleagues of Yusuf Izhar Zaidi

NameDINCompanyDesignation
Md Jamil Ahmed Ansari09126628Imperial Medical Centre LlpDesignated Partner
Mohammad Alam11734895Imperial Medical Centre LlpDesignated Partner
Pradeep Kumar11734896Imperial Medical Centre LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Imperial Medical Centre Llp
Premium access

Shareholding and investment profile for Yusuf Izhar Zaidi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yusuf Izhar Zaidi

Yusuf Izhar Zaidi currently holds 1 directorship: Imperial Medical Centre Llp (Designated Partner, since 22 May 2026).

Yusuf Izhar Zaidi was first appointed on 22 May 2026 as Designated Partner at Imperial Medical Centre Llp.

The current boards of Yusuf Izhar Zaidi's companies include Md Jamil Ahmed Ansari (Imperial Medical Centre Llp), Mohammad Alam (Imperial Medical Centre Llp), Pradeep Kumar (Imperial Medical Centre Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available